Market Place
Sourcing Support
Merck`s HIV combo treatment meets efficacy bar in Ph 3 trials
20 Dec 2024 //
FIERCE BIOTECH
Merck Opens Enrollment in PIII with Islatravir in Combination with Doravirine
22 Feb 2023 //
BUSINESSWIRE
Merck to start studying lower dose of HIV drug after FDA hold
21 Sep 2022 //
REUTERS
Merck HIV combo pill compares to existing meds in phase 3 trials
28 Oct 2021 //
FIERCEBIOTECH
Merck Announces New Analyses Showing Additional Safety & Efficacy for Islatravir
06 Jul 2020 //
BUSINESSWIRE
Merck Underscores Commitment to HIV with New Data Analyses at AIDS 2020
24 Jun 2020 //
BIOSPACE
FDA ends CSR pilot, plots new approach for disclosing study reports
28 Mar 2020 //
ENDPTS
Merck’s PIFELTRO™ and DELSTRIGO™ get FDA permission to treat HIV-1
25 Sep 2019 //
BIOSPECTRUMASIA
Merck`s Big Week: HIV Approval and Landmark 3-Country Approval for Keytruda
20 Sep 2019 //
BIOSPACE
FDA Action Alert: Merck and Amarin
16 Sep 2019 //
BIOSPACE
FDA Plots Shift Away From CSR Pilot to Forge New Transparency on Drug Approval
27 Jun 2019 //
RAPS
Yale Researchers Discover Protein in the Immune System Can Help Suppress HIV
22 Jan 2019 //
BIOSPACE
Merck Announces Week 96 Data from Delstrigo for HIV-1
04 Oct 2018 //
BUSINESSWIRE
Merck’s HIV Therapy Delstrigo Meets Primary Efficacy Endpoint
04 Oct 2018 //
BUSINESSWIRE
CHMP puts 13 therapies forward for EU approval
24 Sep 2018 //
PHARMA TIMES
FDA Approves Eight Novel Drugs in August
03 Sep 2018 //
BIOSPACE
US approves MSD HIV drugs Delstrigo and Pifeltro
31 Aug 2018 //
PHARMA TIMES
FDA approves two new HIV drugs from Merck
31 Aug 2018 //
REUTERS
FDA Approves Merck’s DELSTRIGO Tablet as a Complete Regimen and PIFELTRO™
31 Aug 2018 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.